SinoMab BioScience

3681 · HKEX

Public Market Listing

3681HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for SinoMab BioScience are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 2
IL-17RB (IL-25 receptor)Monoclonal antibody
Atopic Dermatitis

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
April 2027 (1)
SM17Phase 2Atopic Dermatitis
Est. primary completion 2027-04-25 · NCT07445919 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

Annual history (1 year)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY———$3.7Mreport ↗